Protalix BioTherapeutics (PLX) Prepaid Assets (2014 - 2026)
Protalix BioTherapeutics' quarterly Prepaid Assets came in at $1.1 million in Q1 2026, down 27.74% year-on-year from $1.6 million in Q1 2025, and up 1.77% quarter-over-quarter from $1.1 million in Q4 2025.
Protalix BioTherapeutics has reported Prepaid Assets for 13 years, with the latest figure at $1.1 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 27.74% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (down 27.74% YoY), and the FY2025 full-year result was $1.1 million, up 125.8% from the prior year.
- Prepaid Assets for Q1 2026 stood at $1.1 million, up from $1.1 million in the prior quarter.
- The five-year high for Prepaid Assets was $2.6 million in Q2 2022, with the low at $444000.0 in Q4 2023.
- Average Prepaid Assets over 5 years is $1.3 million, with a median of $1.1 million recorded in 2026.
- Year-over-year, Prepaid Assets plunged 66.11% in 2023 and surged 125.8% in 2025.
- Tracing PLX's Prepaid Assets over 5 years: stood at $1.3 million in 2022, then sank by 66.11% to $444000.0 in 2023, then grew by 12.61% to $500000.0 in 2024, then surged by 125.8% to $1.1 million in 2025, then grew by 1.77% to $1.1 million in 2026.
- The last three Prepaid Assets figures came in at $1.1 million (Q1 2026), $1.1 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.15 Mn |
| Dec 31, 2025 | 1.13 Mn |
| Sep 30, 2025 | 1.45 Mn |
| Jun 30, 2025 | 1.51 Mn |
| Mar 31, 2025 | 1.59 Mn |
| Dec 31, 2024 | 500,000.00 |
| Sep 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 1.49 Mn |
| Mar 31, 2024 | 812,000.00 |
| Dec 31, 2023 | 444,000.00 |
| Sep 30, 2023 | 1.13 Mn |
| Jun 30, 2023 | 1.71 Mn |
| Mar 31, 2023 | 758,000.00 |
| Dec 31, 2022 | 1.31 Mn |
| Sep 30, 2022 | 1.74 Mn |
| Jun 30, 2022 | 2.60 Mn |
| Mar 31, 2022 | 1.12 Mn |
| Dec 31, 2021 | 905,000.00 |
| Sep 30, 2021 | 2.27 Mn |
| Jun 30, 2021 | 3.01 Mn |
| Mar 31, 2021 | 1.75 Mn |
| Dec 31, 2020 | 841,000.00 |
| Sep 30, 2020 | 2.61 Mn |
| Jun 30, 2020 | 2.89 Mn |
| Mar 31, 2020 | 2.73 Mn |
| Dec 31, 2019 | 1.83 Mn |
| Sep 30, 2019 | 2.76 Mn |
| Jun 30, 2019 | 2.25 Mn |
| Mar 31, 2019 | 1.71 Mn |
| Dec 31, 2018 | 1.88 Mn |
| Sep 30, 2018 | 2.62 Mn |
| Jun 30, 2018 | 2.50 Mn |
| Mar 31, 2018 | 2.59 Mn |
| Dec 31, 2017 | 1.93 Mn |
| Sep 30, 2017 | 2.69 Mn |
| Jun 30, 2017 | 4.08 Mn |
| Mar 31, 2017 | 3.48 Mn |
| Dec 31, 2016 | 2.65 Mn |
| Sep 30, 2016 | 1.05 Mn |
| Jun 30, 2016 | 5.14 Mn |
| Mar 31, 2016 | 2.95 Mn |
| Dec 31, 2015 | 1.67 Mn |
| Dec 31, 2014 | 2.20 Mn |